Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Feasibility of anti-VEGF agent bevacizumab in patients with Crohn's disease.

× No keyword cloud information.

5 in total

1. Role of Dopamine and D2 Dopamine Receptor in the Pathogenesis of Inflammatory Bowel Disease.

Authors: Ganna Tolstanova; Xiaoming Deng; Amrita Ahluwalia; Brankica Paunovic; Alona Prysiazhniuk; Lyudmyla Ostapchenko; Andrzej Tarnawski; Zsuzsanna Sandor; Sandor Szabo
Journal: Dig Dis Sci Date: 2015-05-14 Impact factor: 3.199

2. Safety and Efficacy of Bevacizumab in Cancer Patients with Inflammatory Bowel Disease.

Authors: Ruth Gabriela Herrera-Gómez; Miruna Grecea; Claire Gallois; Valérie Boige; Patricia Pautier; Barbara Pistilli; David Planchard; David Malka; Michel Ducreux; Olivier Mir
Journal: Cancers (Basel) Date: 2022-06-13 Impact factor: 6.575

3. Angiogenesis and Vascular Endothelial Growth Factor-A Expression Associated with Inflammation in Pediatric Crohn's Disease.

Authors: J Leslie Knod; Kelly Crawford; Mary Dusing; Margaret H Collins; Artur Chernoguz; Jason S Frischer
Journal: J Gastrointest Surg Date: 2015-11-03 Impact factor: 3.452

4. Choroidal neovascularization in a patient with Crohn's disease.

Authors: Giuseppe Casalino; Giuseppe Querques; Federico Corvi; Enrico Borrelli; Giacinto Triolo; Giuseppe Alvise Ramirez; Francesco Bandello
Journal: Case Rep Ophthalmol Date: 2014-08-04

Review 5. Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups.

Authors: Matthias Pinter; Bernhard Scheiner; Markus Peck-Radosavljevic
Journal: Gut Date: 2020-08-03 Impact factor: 23.059

5 in total